Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure.
Yndestad A, Finsen AV, Ueland T, Husberg C, Dahl CP, Øie E, Vinge LE, Sjaastad I, Sandanger Ø, Ranheim T, Dickstein K, Kjekshus J, Damås JK, Fiane AE, Hilfiker-Kleiner D, Lipp M, Gullestad L, Christensen G, Aukrust P. Yndestad A, et al. Among authors: dickstein k. PLoS One. 2012;7(3):e33038. doi: 10.1371/journal.pone.0033038. Epub 2012 Mar 12. PLoS One. 2012. PMID: 22427939 Free PMC article.
[Treatment of heart failure with beta-blockaders].
Gundersen T, Dickstein K, Hole T, Kjekshus J, Myhre ES, Rønnevik P, Smith P, Westheim A. Gundersen T, et al. Among authors: dickstein k. Tidsskr Nor Laegeforen. 1997 Feb 10;117(4):526-8. Tidsskr Nor Laegeforen. 1997. PMID: 9148453 Review. Norwegian.
[Chronic heart failure--suggestion to a management program].
Westheim A, Dickstein K, Gundersen T, Hole T, Kjekshus J, Myhre ES, Rønnevik PK, Samstad S, Smith P. Westheim A, et al. Among authors: dickstein k. Tidsskr Nor Laegeforen. 1999 Sep 30;119(23):3427-31. Tidsskr Nor Laegeforen. 1999. PMID: 10553340 Review. Norwegian.
Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
Dickstein K, Kjekshus J; OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan. Dickstein K, et al. Am J Cardiol. 2001 Mar 15;87(6):766-71, A7. doi: 10.1016/s0002-9149(00)01500-9. Am J Cardiol. 2001. PMID: 11249900 Clinical Trial.
499 results